- Home
- Publications
- Publication Search
- Publication Details
Title
The Intriguing History of Cancer Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-12-17
DOI
10.3389/fimmu.2019.02965
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CRISPR/Cas9-based genome editing in the Era of CAR T cell immunotherapy
- (2019) January Salas-Mckee et al. Human Vaccines & Immunotherapeutics
- Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
- (2019) Chin-King Looi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor neoantigens: from basic research to clinical applications
- (2019) Tao Jiang et al. Journal of Hematology & Oncology
- Neoantigen vaccine: an emerging tumor immunotherapy
- (2019) Miao Peng et al. Molecular Cancer
- Mutation-Derived Neoantigens for Cancer Immunotherapy
- (2019) John C. Castle et al. Frontiers in Immunology
- The Immune Revolution: A Case for Priming, Not Checkpoint
- (2018) Robert H. Vonderheide CANCER CELL
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
- (2018) Vancheswaran Gopalakrishnan et al. CANCER CELL
- An Update on Immunotherapy for Solid Tumors: A Review
- (2018) Toan Pham et al. ANNALS OF SURGICAL ONCOLOGY
- CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment
- (2018) Hasan Mollanoori et al. HUMAN IMMUNOLOGY
- Natural Killer Cells: Development, Maturation, and Clinical Utilization
- (2018) Alex M. Abel et al. Frontiers in Immunology
- Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
- (2018) Roberto Ferrara et al. JAMA Oncology
- Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
- (2018) Yinghong Wang et al. NATURE MEDICINE
- Personalized tumor vaccines keep cancer in check
- (2017) Jocelyn Kaiser SCIENCE
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models
- (2017) William K. Decker et al. Frontiers in Immunology
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- Cancer immunotherapy targeting neoantigens
- (2016) Yong-Chen Lu et al. SEMINARS IN IMMUNOLOGY
- Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention
- (2016) Nadia F. Nocera et al. Frontiers in Pharmacology
- Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers
- (2015) Felicia Fei-Lei Chung et al. CURRENT CANCER DRUG TARGETS
- Going viral: a review of replication-selective oncolytic adenoviruses
- (2015) Christopher Larson et al. Oncotarget
- 4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy
- (2014) Dass S. Vinay et al. BMB Reports
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Immunosuppressants in cancer prevention and therapy
- (2014) Mikhail V Blagosklonny OncoImmunology
- Rituximab causes a polarization of B cells that augments its therapeutic function in NK-cell-mediated antibody-dependent cellular cytotoxicity
- (2013) D. Rudnicka et al. BLOOD
- CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
- (2013) J. Xu et al. CANCER RESEARCH
- Targeting immunosuppression for cancer therapy
- (2013) Cristina Ghirelli et al. JOURNAL OF CLINICAL INVESTIGATION
- HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
- (2012) Anupama Sharma et al. CANCER
- Cancer and the Immune System
- (2012) CELL
- Immunotherapy of Cancer with 4-1BB
- (2012) D. S. Vinay et al. MOLECULAR CANCER THERAPEUTICS
- Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase
- (2012) B. Ravishankar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- “Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy
- (2010) Federico Garrido et al. INTERNATIONAL JOURNAL OF CANCER
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited
- (2009) William K. Decker et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
- (2008) Tanja D. de Gruijl et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started